2.03% 0.0199

Kronos Bio Inc (KRON)

Kronos Bio Inc Borsa (KRON) Ultime notizie

Kronos Bio Inc (KRON)

Kronos Bio Inc Borsa (KRON) Ultime notizie

Kronos Bio, Inc. (NASDAQ:KRON) Position Increased by Forefront Analytics LLC - Defense World

Kronos Bio to Present Data at ACR Convergence 2024 to Support p300 KAT Inhibition as an Approach to Anti-Inflammatory Therapy - StockTitan

Kronos Bio to Present Data at ACR Convergence 2024 to - GlobeNewswire

Layoff Tracker: Bluebird Bio to Cut 25% of Workforce and More News - BioSpace

Keros Therapeutics (NASDAQ:KROS) Shares Gap Up to $55.80 - Defense World

Avoro Capital Advisors LLC Reduces Position in Krystal Biotech, Inc. (NASDAQ:KRYS) - Defense World

Integral Health Asset Management LLC Acquires 45,000 Shares of Keros Therapeutics, Inc. (NASDAQ:KROS) - Defense World

How the (KROS) price action is used to our Advantage - Stock Traders Daily

How does Keros Therapeutics Inc (KROS) change from a tortoise to a hare? - SETE News

Kronos Bio highlights istisociclib data at Ovarian Cancer Research Symposium - TipRanks

71,428 Shares in Korro Bio, Inc. (NASDAQ:KRRO) Acquired by Tri Locum Partners LP - MarketBeat

Kronos Bio Highlights Data at AACR Ovarian Cancer Research - GlobeNewswire

Kronos Bio Highlights Data at AACR Ovarian Cancer Research Symposium that Supports Clinical Evaluation of Istisociclib in Advanced Ovarian Cancer - StockTitan

Keros Therapeutics (NASDAQ:KROS) Receives New Coverage from Analysts at Guggenheim - MarketBeat

Guggenheim starts Keros Therapeutics with 'buy' on lung disorder drug potential - XM

Guggenheim bullish on Keros Therapeutics stock driven by PAH treatment prospects - Investing.com Australia

Gogo Inc. (NASDAQ:GOGO) Shares Sold by Yarra Square Partners LP - Defense World

American Century Companies Inc. Has $13.63 Million Stock Holdings in Keros Therapeutics, Inc. (NASDAQ:KROS) - Defense World

Keros Therapeutics, Inc. (NASDAQ:KROS) Shares Bought by Rhumbline Advisers - Defense World

Pharmacosmos after major acquisition: “The next six months are about integrating G1 well” - MedWatch

Understanding CRON stock ratios for better investment decisions - US Post News

DekaBank Deutsche Girozentrale Has $4.25 Million Holdings in Dollar Tree, Inc. (NASDAQ:DLTR) - Defense World

Kronos Bio, Inc. (NASDAQ:KRON) Short Interest Update - MarketBeat

ABIVAX Société Anonyme (NASDAQ:ABVX) Sees Large Growth in Short Interest - Defense World

After Plunging -5.53% in 4 Weeks, Here's Why the Trend Might Reverse for Kronos Bio (KRON) - Yahoo Finance

Kronos Bio Announces Participation in Medical and Investor Conferences in September - Marketscreener.com

Kronos Bio Announces Participation in Medical and Investor Conferences in September - GlobeNewswire

Kronos Bio Announces Participation in Medical and Investor Conferences in September - Yahoo Finance

The Psychology of Kronos Bio Inc Inc. (KRON) Price Performance: Understanding Market Sentiment - The InvestChronicle

Kronos Bio Inc (KRON) rating initates by Berenberg - Knox Daily

HC Wainwright Equities Analysts Boost Earnings Estimates for Kronos Bio, Inc. (NASDAQ:KRON) - MarketBeat

Kronos Bio (NASDAQ:KRON) Given "Buy" Rating at HC Wainwright - MarketBeat

Kronos Bio (NASDAQ:KRON) Earns Buy Rating from HC Wainwright - Defense World

KRON (Kronos Bio) Cash From Other Investing Activities : $0.00 Mil (TTM As of Jun. 2024) - GuruFocus.com

Analyzing Kronos Bio Inc (KRON) After Recent Trading Activity - Knox Daily

Kronos Bio Second Quarter 2024 Earnings: Beats Expectations - Yahoo Finance

KRON Stock Earnings: Kronos Bio Beats EPS, Beats Revenue for Q2 2024 - InvestorPlace

10x Genomics (TXG) Reports Q2 Loss, Tops Revenue Estimates - Zacks Investment Research

Kronos Bio Reports Second Quarter 2024 Financial Results and Pipeline Update - GlobeNewswire

Kronos Bio Reports Second Quarter 2024 Financial Results and Pipeline Update - StockTitan

Kronos Bio Reports Second Quarter 2024 Financial Results and Pipeline Update - Yahoo Finance

Kronos Bio, Inc. (KRON) Expected to Beat Earnings Estimates: Should You Buy? - MSN

Kronos Bio, Inc. (KRON) Expected to Beat Earnings Estimates: Should You Buy? - Yahoo Finance

HC Wainwright Comments on Kronos Bio, Inc.'s Q2 2024 Earnings (NASDAQ:KRON) - MarketBeat

Kronos Bio (NASDAQ:KRON) Rating Reiterated by HC Wainwright - American Banking and Market News

Q2 2024 EPS Estimates for Kronos Bio, Inc. (NASDAQ:KRON) Boosted by HC Wainwright - Defense World

Jacobs Levy Equity Management Inc. Has $77,000 Holdings in Kronos Bio, Inc. (NASDAQ:KRON) - Defense World

Kronos Bio, Inc. (NASDAQ:KRON) Expected to Post FY2025 Earnings of ($1.44) Per Share - Defense World

Benessere Capital Acquisition (OTCMKTS:BENEU) Shares Down 0% - Defense World

HC Wainwright Reiterates Buy Rating for Kronos Bio (NASDAQ:KRON) - Defense World

Kronos Bio, Inc. Forecasted to Post FY2025 Earnings of ($1.44) Per Share (NASDAQ:KRON) - MarketBeat

HC Wainwright Reaffirms "Buy" Rating for Kronos Bio (NASDAQ:KRON) - MarketBeat

Kronos Bio, Inc. (NASDAQ:KRON) Sees Large Increase in Short Interest - Defense World

Assertio Holdings And 2 Other Penny Stocks Insiders Are Buying - MSN

Biopharma Layoff Tracker 2024: Cue, Anokion, GlycoMimetics and More Cut Staff - BioSpace

Simile a KRON